Near Elimination of Hepatitis B Virus Infections Among Hawaii Elementary School Children After Universal Infant Hepatitis B Vaccination
Overview
Authors
Affiliations
Objectives: Hawaii implemented routine infant hepatitis B vaccination in 1992 and required it for school entry in 1997. Previously, in 1989, a serologic survey among Hawaii school children in grades 1 to 3 indicated that 1.6% had chronic hepatitis B virus infection, and 2.1% had resolved infection. We conducted a follow-up survey to examine changes in hepatitis B virus infection rates.
Patients And Methods: This study was performed in Oahu, Hawaii, during the 2001-2002 school year among children in grades 2 and 3. Consenting parents/guardians provided demographic information including place of birth. Participants were tested for serologic evidence of hepatitis B virus infection and their vaccination status was determined by reviewing school records. Rates of symptomatic acute hepatitis B among persons aged < or = 19 years were calculated from cases reported from Hawaii to the Centers for Disease Control and Prevention between 1990 and 2004.
Results: Completed hepatitis B vaccination series were documented for 83% of the 2469 participants by age 18 months and for 97% by age 5 years. Past or present hepatitis B virus infection was detected among 6 participants (0.24%), including 1 (0.04%) with chronic infection and 5 (0.20%) with resolved infections. Compared with the 1989 survey, these prevalences represent declines of 97% and 90% in chronic and resolved hepatitis B virus infections, respectively. The incidence of symptomatic acute hepatitis B in Hawaii children and adolescents aged < or = 19 years decreased from 4.5 cases per 100,000 in 1990 to 0.0 during 2002-2004. To date, the last reported case in a child aged < 15 years in Hawaii occurred in 1996.
Conclusions: Hepatitis B virus infection has nearly been eliminated in Hawaii children born after universal infant hepatitis B vaccination was implemented. These findings suggest that hepatitis B prevention goals are being met through routine immunization and related prevention programs among US children.
An overview of occult hepatitis B infection (OBI) with emphasis on HBV vaccination.
Delghandi S, Raoufinia R, Shahtahmasbi S, Meshkat Z, Gouklani H, Gholoobi A Heliyon. 2024; 10(17):e37097.
PMID: 39281486 PMC: 11402251. DOI: 10.1016/j.heliyon.2024.e37097.
Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas.
Alvarez A, Perez-Vilar S, Pacis-Tirso C, Contreras M, El Omeiri N, Ruiz-Matus C BMC Public Health. 2017; 17(1):325.
PMID: 28415981 PMC: 5392937. DOI: 10.1186/s12889-017-4227-6.
Tarakji B, Ashok N, Alakeel R, Azzeghaibi S, Umair A, Darwish S Ann Med Health Sci Res. 2014; 4(6):829-36.
PMID: 25506472 PMC: 4250977. DOI: 10.4103/2141-9248.144870.
Saffar H, Saffar M, Ajami A, Khalilian A, Shams-Esfandabad K, Mirabi A Hepat Mon. 2014; 14(9):e22223.
PMID: 25368659 PMC: 4214124. DOI: 10.5812/hepatmon.22223.
The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology.
Goyal A, Murray J PLoS One. 2014; 9(10):e110143.
PMID: 25313681 PMC: 4196970. DOI: 10.1371/journal.pone.0110143.